Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(S)-Higenamine hydrobromide, an S-enantiomer of Higenamine, serves as the preliminary compound in benzylisoquinoline alkaloid biosynthesis. It is formed through the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) via norcoclaurine synthase (NCS)[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 162.00 |
Description | (S)-Higenamine hydrobromide, an S-enantiomer of Higenamine, serves as the preliminary compound in benzylisoquinoline alkaloid biosynthesis. It is formed through the condensation of dopamine and 4-hydroxyphenylacetaldehyde (4-HPAA) via norcoclaurine synthase (NCS)[1]. |
In vitro | The biosynthetic pathway for benzylisoquinoline alkaloids begins with the enzyme-catalyzed condensation of dopamine and 4-hydrophenylacetaldehyde, producing (S)-norcoclaurine. These substrates are secondary metabolites stemming from the decarboxylation, hydroxylation, and deamination of tyrosine[1]. |
Molecular Weight | 352.228 |
Formula | C16H18BrNO3 |
CAS No. | 105990-27-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(S)-Higenamine hydrobromide 105990-27-0 (S) Higenamine hydrobromide (S)Higenamine hydrobromide Higenamine Hydrobromide inhibitor inhibit